Racial Differences in the Diagnosis and Treatment of Prostate Cancer
Giuliano Di Pietro, Ganna Chornokur, Nagi B. Kumar, Chemar Davis, Jong Y. Park
Int Neurourol J. 2016;20(Suppl 2):S112-119.   Published online 2016 Nov 22
DOI: https://doi.org/10.5213/inj.1632722.361
Citations to this article as recorded by
  Crossref logo
Is Retzius-sparing robot-assisted radical prostatectomy associated with better functional and oncological outcomes? Literature review and meta-analysis
Najib Isse Dirie, Gaurab Pokhrel, Wei Guan, Mukhtar Adan Mumin, Jun Yang, Jackson Ferdinand Masau, Henglong Hu, Shaogang Wang
Asian Journal of Urology.2019; 6(2): 174.     CrossRef
Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer
Marieke J. Krimphove, Alexander P. Cole, Sean A. Fletcher, Sabrina S. Harmouch, Sebastian Berg, Stuart R. Lipsitz, Maxine Sun, Junaid Nabi, Paul L. Nguyen, Jim C. Hu, Adam S. Kibel, Toni K. Choueiri, Luis A. Kluth, Quoc-Dien Trinh
Prostate Cancer and Prostatic Diseases.2019; 22(1): 125.     CrossRef
African American Health and Posttraumatic Slave Syndrome: A Terror Management Theory Account
Michael J. Halloran
Journal of Black Studies.2019; 50(1): 45.     CrossRef
All Men Are Created Equal: Addressing Disparities in Prostate Cancer Care
Hala Borno, Daniel J. George, Lowell E. Schnipper, Franco Cavalli, Thomas Cerny, Silke Gillessen
American Society of Clinical Oncology Educational Book.2019; (39): 302.     CrossRef
Les cancers urologiques primitifs dans un contexte de ressources limitées : épidémiologie et traitement
Souleymane Ouedraogo, Mamadou T. Traore, Jean L. Kambire, Salam Ouedraogo, Bernadette Bere, Aristide F. Kabore
Bulletin du Cancer.2019; 106(10): 868.     CrossRef
Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics
Libby Ellis, Alison J. Canchola, David Spiegel, Uri Ladabaum, Robert Haile, Scarlett Lin Gomez
Journal of Clinical Oncology.2018; 36(1): 25.     CrossRef
Analysis of Tumor Biology to Advance Cancer Health Disparity Research
Cheryl J. Smith, Tsion Z. Minas, Stefan Ambs
The American Journal of Pathology.2018; 188(2): 304.     CrossRef
Ethnic differences in TGFβ-signaling pathway may contribute to prostate cancer health disparity
Bethtrice Elliott, DeAdra L Zackery, Vanessa A Eaton, Re’Josef T Jones, Fisseha Abebe, Camille C Ragin, Shafiq A Khan
Carcinogenesis.2018; 39(4): 546.     CrossRef
Exercise and prostate cancer: From basic science to clinical applications
Christian Campos, Paula Sotomayor, Daniel Jerez, Javier González, Camila B. Schmidt, Katharina Schmidt, Winfried Banzer, Alejandro S. Godoy
The Prostate.2018; 78(9): 639.     CrossRef
African-American men and prostate cancer-specific mortality: a competing risk analysis of a large institutional cohort, 1989-2015
Vonetta L. Williams, Shivanshu Awasthi, Angelina K. Fink, Julio M. Pow-Sang, Jong Y. Park, Travis Gerke, Kosj Yamoah
Cancer Medicine.2018; 7(5): 2160.     CrossRef
Cancer survival among Alaska Native people
Sarah H. Nash, Angela L. W. Meisner, Garrett L. Zimpelman, Marc Barry, Charles L. Wiggins
Cancer.2018; 124(12): 2570.     CrossRef
Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial
Eric A. Miller, Paul F. Pinsky, Amanda Black, Gerald L. Andriole, Dudith Pierre-Victor
The Prostate.2018; 78(11): 830.     CrossRef
Racial disparities in guideline-concordant cancer care and mortality in the United States
Penny Fang, Weiguo He, Daniel Gomez, Karen E. Hoffman, Benjamin D. Smith, Sharon H. Giordano, Reshma Jagsi, Grace L. Smith
Advances in Radiation Oncology.2018; 3(3): 221.     CrossRef
Nutraceuticals in prostate cancer therapeutic strategies and their neo-adjuvant use in diverse populations
Dominique Reed, Komal Raina, Rajesh Agarwal
npj Precision Oncology.2018;[Epub]     CrossRef
Predictors of well-being and quality of life in men who underwent radical prostatectomy: longitudinal study
Adilson Edson Romanzini, Maria da Graça Pereira, Caroline Guilherme, Adauto José Cologna, Emilia Campos de Carvalho
Revista Latino-Americana de Enfermagem.2018;[Epub]     CrossRef
LXRs, SHP, and FXR in Prostate Cancer: Enemies or Ménage à Quatre With AR?
Marica Cariello, Simon Ducheix, Salwan Maqdasy, Silvère Baron, Antonio Moschetta, Jean-Marc A. Lobaccaro
Nuclear Receptor Signaling.2018; 15: 155076291880107.     CrossRef
miRNAs associated with prostate cancer risk and progression
Hung N. Luu, Hui-Yi Lin, Karina Dalsgaard Sørensen, Olorunseun O. Ogunwobi, Nagi Kumar, Ganna Chornokur, Catherine Phelan, Dominique Jones, LaCreis Kidd, Jyotsna Batra, Kosj Yamoah, Anders Berglund, Robert J. Rounbehler, Mihi Yang, Sang Haak Lee, Nahyeon
BMC Urology.2017;[Epub]     CrossRef
Are We Ready to Use the Omics Strategies for Precision Medicine?
Jayoung Kim
International Neurourology Journal.2016; 20(Suppl 2): S65.     CrossRef